US group questions human embryo research, calls for rules
By DPA,
Deutsche Presse-Agentur [cites Marcy Darnovsky]
| 05. 14. 2008
A US public interest group has called for the US to set up national bioethics standards and regulations on embryonic research after a group of scientists in New York State produced a genetically-engineered embryo, dpa reported.
The Center for Genetics and Society, located in Oakland, California, said Tuesday the need for such standards was clear after the research at Cornell University was brought to light by a London newspaper over the weekend. Britain is in the process of revamping its genetic research laws.
Marcy Darnovsky of the Center for Genetics and Society told Deutsche Presse-Agentur dpa that the US urgently needs federal bioethical standards and a regulatory panel similar to those in Canada and Britain or even Germany, which has some of the most stringent rules on genetic research.
"The prospect of genetic technology being used to introduce new types of genetic inequality and social division, to create genetically-enhanced children is the core of our concern," Darnovsky said.
A brief account of the study by scientists at Cornell University was published in September 2007 in the journal Fertility and Sterility...
Related Articles
By staff, Japan Times | 12.04.2025
Japan plans to introduce a ban with penalties on implanting a genome-edited fertilized human egg into the womb of a human or another animal amid concerns over "designer babies."
A government expert panel broadly approved a proposal, including the ban...
By David Jensen, The California Stem Cell Report | 12.11.2025
California’s stem cell and gene therapy agency today approved spending $207 million more on training and education, sidestepping the possibility of using the cash to directly support revolutionary research that has been slashed and endangered by the Trump administration.
Directors...
By Tina Stevens, CounterPunch | 12.11.2025
Silicon Valley and other high tech billionaires are investing millions in start-ups dedicated to creating genetically engineered (GE) babies, according to a recent Wall Street Journal (WSJ) report. AI mogul Sam Altman, cryptocurrency entrepreneur Brian Armstrong, venture capitalist Peter...
By Jenny Lange, BioNews | 12.01.2025
A UK toddler with a rare genetic condition was the first person to receive a new gene therapy that appears to halt disease progression.
Oliver, now three years old, has Hunter syndrome, an inherited genetic disorder that leads to physical...